Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondissolve for Radiation Induced Nausea and Vomiting
NCT02006056Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Nov 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Aiqisu in radiation-induced nausea and vomiting (RINV), sponsored by Sunnybrook Health Sciences Centre. Started Nov 2013; status: completed.
02
Drugs
Aiqisu
03
Conditions
radiation-induced nausea and vomiting (RINV)
Beyond the preview
Go deeper on NCT02006056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02006056.